HYPERSTART C2C Trademark

Trademark Overview

On Tuesday, May 30, 2023, a trademark application was filed for HYPERSTART C2C with the United States Patent and Trademark Office. The USPTO has given the HYPERSTART C2C trademark a serial number of 98019310. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Friday, October 31, 2025. This trademark is owned by BPSI Holdings LLC. The HYPERSTART C2C trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Consulting services relating to the design and formulation of oral solid dosage forms of pharmaceuticals
hyperstart c2c

General Information

Serial Number98019310
Word MarkHYPERSTART C2C
Filing DateTuesday, May 30, 2023
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateFriday, October 31, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 14, 2023

Trademark Statements

Goods and ServicesConsulting services relating to the design and formulation of oral solid dosage forms of pharmaceuticals
Pseudo MarkHYPER START C TWO C

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, June 29, 2023
Primary Code042
First Use Anywhere DateWednesday, June 28, 2023
First Use In Commerce DateWednesday, June 28, 2023

Trademark Owner History

Party NameBPSI Holdings LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressWilmington, DE 19803
Party NameBPSI Holdings LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressWilmington, DE 19803

Trademark Events

Event DateEvent Description
Friday, June 2, 2023NEW APPLICATION ENTERED
Thursday, June 29, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 3, 2023ASSIGNED TO EXAMINER
Sunday, October 8, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 25, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 14, 2023PUBLISHED FOR OPPOSITION
Tuesday, November 14, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 9, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 2, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, July 2, 2024SOU EXTENSION 1 FILED
Tuesday, July 2, 2024SOU EXTENSION 1 GRANTED
Tuesday, July 2, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 30, 2024SOU TEAS EXTENSION RECEIVED
Monday, December 30, 2024SOU EXTENSION 2 FILED
Tuesday, December 31, 2024SOU EXTENSION 2 GRANTED
Monday, March 3, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 19, 2025TEAS STATEMENT OF USE RECEIVED
Saturday, October 25, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, May 19, 2025USE AMENDMENT FILED
Sunday, October 26, 2025STATEMENT OF USE PROCESSING COMPLETE
Friday, October 31, 2025ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, October 31, 2025NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Related Keywords

hyperstart solid dosage forms pharmaceuticals oral formulation services relating design consulting